ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,962
Screening encounters
4,681
Diagnostic referrals
898
Outstanding pathways
320

Screening pathway

  1. Screening4,681Encounters
  2. Positive finding1,615Documented findings
  3. Referral898Diagnostic referrals
  4. Follow-up1,070Diagnostic visits
  5. Outcome578Resolved pathways

Stage totals use different units. Pending pathways: 320. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 1908 · EXP-1908Synthetic · Site D

Full participant history through 2026-12-12, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Repeat plan · HPV DNA · Prior HPV positive · Scheduled for 2026-03-22
  4. · Screening · HPV DNA · Repeat · Prior HPV positive
  5. · Screening result · HPV DNA · HPV detected · Adequate
  6. · Diagnostic referral · EXP-1908-T-R
  7. · Contact attempt · Unsuccessful
  8. · Diagnostic booking · Initial booking
  9. · Contact attempt · Reached
  10. · Diagnostic visit · Attended
  11. · Diagnosis · Colposcopy · Biopsy collected
  12. · Diagnosis · Histopathology · No high-grade lesion identified
  13. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-05-19
  14. · Follow-up disposition · Resolved · EXP-1908-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

3962 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-4760 · Expanded synthetic participant 4760Site C — Rural Outreach Programme
EXP-4761 · Expanded synthetic participant 4761Site C — Rural Outreach Programme
EXP-4762 · Expanded synthetic participant 4762Site D — Community Engagement Programme
EXP-4763 · Expanded synthetic participant 4763Site A — Urban Referral Hub
EXP-4764 · Expanded synthetic participant 4764Site B — Peri-Urban Access Programme
EXP-4766 · Expanded synthetic participant 4766Site E — Resource-Constrained Navigation Programme
EXP-4767 · Expanded synthetic participant 4767Site E — Resource-Constrained Navigation Programme
EXP-4768 · Expanded synthetic participant 4768Site E — Resource-Constrained Navigation Programme
EXP-4769 · Expanded synthetic participant 4769Site D — Community Engagement Programme
EXP-4770 · Expanded synthetic participant 4770Site A — Urban Referral Hub
EXP-4771 · Expanded synthetic participant 4771Site A — Urban Referral Hub
EXP-4772 · Expanded synthetic participant 4772Site C — Rural Outreach Programme
EXP-4773 · Expanded synthetic participant 4773Site C — Rural Outreach Programme
EXP-4775 · Expanded synthetic participant 4775Site A — Urban Referral Hub
EXP-4777 · Expanded synthetic participant 4777Site A — Urban Referral Hub
EXP-4778 · Expanded synthetic participant 4778Site C — Rural Outreach Programme
EXP-4779 · Expanded synthetic participant 4779Site D — Community Engagement Programme
EXP-4780 · Expanded synthetic participant 4780Site B — Peri-Urban Access Programme
EXP-4781 · Expanded synthetic participant 4781Site C — Rural Outreach Programme
EXP-4785 · Expanded synthetic participant 4785Site A — Urban Referral Hub
EXP-4789 · Expanded synthetic participant 4789Site D — Community Engagement Programme
EXP-4790 · Expanded synthetic participant 4790Site C — Rural Outreach Programme
EXP-4791 · Expanded synthetic participant 4791Site A — Urban Referral Hub
EXP-4792 · Expanded synthetic participant 4792Site B — Peri-Urban Access Programme
EXP-4793 · Expanded synthetic participant 4793Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
1784
HPV DNA
2235
Cytology
662

Navigation activity

Barrier documented
798
Contact attempt
1313
Navigation intervention
341
Diagnostic booking
1119
Diagnostic visit
1070

Documented barriers

Contact difficulty
256
Transport difficulty
262
Appointment coordination
280

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.